A month after losing its lead program, Unity Biotechnology cuts 30% of staff in restructuring

Unity Biotechnology’s lead anti-aging program faced the chopping block last month following a major Phase II flop. And now, 30% of its staff are …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

A month af­ter los­ing its lead pro­gram, Uni­ty Biotech­nol­o­gy cuts 30% of staff in re­struc­tur­ing